A WHO grade II meningioma characterized by the presence of an increased mitotic activity or at least three of the following morphologic features: small cells, high cellularity, prominent nucleoli, lack of architectural pattern, and necrosis. The disease is Atypical Meningioma (EFO_1000101, an Experimental Factor Ontology identifier).